News & events

Our cGMP manufacturing facilities make Novo Nordisk Pharmatech the leading supplier of pharmaceutical grade Quats for a wide range of applications. See how we ensure the highest standards of quality, purity and batch-to-batch consistency here at our site in Køge, Denmark. Controlling for quality, purity and consistency Being cGMP certified, we ensure that every aspect of our manufacturing process is in control – from our own suppliers to the finished product. From the very beginning, we source the best raw ingredients, which are sampled to check they are in specification. Throughout manufacturing, we monitor the critical parameters for each process, ... read more

Thursday 12.11.2020

For many pharmaceutical and biopharmaceutical companies, the coronavirus pandemic has put supply chains to the test, while regulatory requirements are increasingly tightening. Novo Nordisk Pharmatech helps customers reduce their risk, with a high level of consistency in both the quality and supply of our Quats and Human Insulin AF. You can be sure you get the same high quality product, time after time, reliably delivered through local distribution networks. Our comprehensive documentation package and tailored support, which continues through the whole product life cycle, gives you total peace of mind. (Download the article here) High quality Quats and Insulin Human ... read more

Thursday 22.10.2020

Within the biopharma industry, consistency is key – not just from your product but from your supplier. We spoke with two experts from Thermo Fisher Scientific about how they meet their customers’ challenges together with Novo Nordisk Pharmatech. Thermo Fisher Scientific is one of the largest suppliers to the biopharma industry, supporting both commercial bioproduction and biosciences. The company serves a broad range of customers. In bioproduction alone, Thermo Fisher Scientific works with every application of cell culture, from vaccines, to cell and gene therapy and even with artificial meats. The one thing all its customers have in common? The ... read more

Wednesday 14.10.2020

If you want to reduce the risk for your raw materials, pharma-grade Quats is the way to go – both for APIs and expients. We are at Novo Nordisk Pharmatech specialists and a dedicated manufacturer of Quats in an unequalled, full cGMP grade. With our stringent Quality Management System, we ensure the right quality products, with a high degree of consistency. We receive excellent ratings in audits from our customers and authorities, including the FDA and EMA. Our multi-compendial range of Quats complies to the highest regulatory guidelines, including ICH Q7, the European Pharmacopoeia (Ph. Eur.) and the United States ... read more

Thursday 08.10.2020

Why use recombinant Insulin in DoE for your media development? On October 6-7 we will make our debut at Cell Series UK virtual conferences. We are contributing to the Cell Culture and Bioprocessing conference track on Cell Media with the presentation: Why Use Recombinant Insulin in DoE For Your Media Development. The presentation will feature a case study by the University of Barcelona based on the use of a DOE model for determining optimal levels of nutrients in cell culture media for CHO-S cells. We will as well as examine the use of human insulin in association with CHO cells ... read more

Tuesday 29.09.2020

Do you want to join CPhI Festival of Pharma for free? The world’s largest pharmaceutical virtual meeting is launched to bring the global pharma industry together online. The 10-day event (October 5-16, 2020) will welcome thousands of attendees and offers you best-in-class networking, learning and sourcing opportunities. Novo Nordisk Pharmatech A/S will maintain the longstanding relationship with CPhI and is Platinum Sponsor of the online event, sponsoring the keynote: “How will lessons learnt from COVID-19 shape new EU pharmaceutical policy”. This hour long session will be webcast Monday October 5, beginning at 1100 hrs. CET. Join us and get knowledge ... read more

Thursday 24.09.2020

With Insulin Human AF, you avoid the risk of impurities such as mycoplasmas, which can pass line to line from the upstream bioreactor and contaminate your whole line. Our high quality Insulin Human AF is manufactured by our parent company, Novo Nordisk, a leading supplier of insulin for almost 100 years. Novo Nordisk manufactures its Insulin Human AF in cGMP facilities, following an ISO 9001 quality system. With very few manufacturing batches a year, the large scale of our manufacturing and our highly standardised processes ensure product consistency. The insulin is analysed according to the current European Pharmacopoeia (Ph. Eur.) ... read more

Thursday 17.09.2020

How can you mitigate your raw material risk, especially during a pandemic? The COVID-19 crisis has reinforced the importance of having a strong supply chain and a risk-management and business-continuity plan. What selection criteria and which risks have you identified? To understand risks related to supply, demand, material supplier capacities, and so on, you need information that can come only from communicating with your supplier about the stability of supply, production capacity, and transportation and distribution chain. Read about the complete capabilities review and learn more about raw material risk mitigation here. The article was published in the BPI Industry ... read more

Thursday 10.09.2020

“I feel like as an intern I got the opportunity to explore my field of study within a company which values a student’s perspective, and does not hesitate to give its interns responsibility in the task they solve,” explains Emma Lillebro Striib Nielsen, former student intern and now student assistant. Every semester, we welcome local and international students to gain hands-on experience in a leading global pharma company. For the six months they’re with us, each intern becomes an integral part of the team, with meaningful responsibilities – and challenges – that will allow them to grow and distinguish themselves ... read more

Thursday 03.09.2020

With regulations tightening and supply chains shifting, we asked a Brenntag expert with more 40 years’ experience in the industry how Brenntag and Novo Nordisk Pharmatech can support the US pharma market – now and in the future.  Brenntag is the global market leader in chemical and ingredients distribution. Brenntag Specialities is dedicated to high value pharmaceutical APIs, pharma excipients, personal care, nutritional and material science products, with exclusive relationships with the manufacturers it represents, including Novo Nordisk Pharmatech. (You can download the article here.) Joseph Giaimo is Senior Director of Sales for Life Sciences and Marketing Manager for the Novo ... read more

Thursday 27.08.2020

Whether you are an employee, a manager or a business owner, we share a common goal – we don’t want anyone to get hurt on the job. Therefore, employee health and safety conditions are incorporated in all our work tasks. We are now certified to ISO 45001, the newest ISO standard within OH&S (occupational health & safety). ISO 45001 has become one of the most eagerly awaited standards in the world and is set to drastically improve levels of workplace safety. Compared to the former benchmark for OH&S, ISO 45001 considers both risk and opportunities and includes the views of ... read more

Thursday 13.08.2020

Our recombinant insulin is a key component in serum free growth media for mammalian cells. It is used in many cell lines, such as CHO-s, HEK 293 or Sf9, for the manufacturing of monoclonal antibodies, virus vaccines and gene therapy products. It can also be used in other biological drug products approved by regulatory bodies worldwide, including FDA and EMA. We maintain our position as the leading supplier of insulin for cell culture processes by providing excellence at every step of the supply chain – beginning with the quality of our insulin, which is sourced directly from Novo Nordisk, the ... read more

Friday 07.08.2020

We are taking our ambition to be as green as possible to a new level. Now by offering our employees the possibility to commute in a green way. As a natural consequence of our Circular for Zero environmental strategy we have established 10 parking spaces with charging stations for electric vehicles. This makes it even more attractive to commute in a green way. Our employee Lene Hoffmeyer Nielsen is very pleased with the new parking spaces: “The new charging stations at our site is the main reason why we have ordered a Plug-in hybrid car. The possibility to get the ... read more

Friday 31.07.2020

Supply chain safety, quality and reliability are key to all our Quats and Insulin Human customers. Here is how we can help you secure your supply chain, from sourcing raw materials to delivering your products as promised – even in a global crisis. A secure supply from a pharma organisation As part of a large pharma group, we are uniquely positioned to help both our Quats and Insulin Human customers secure their supply chains. We source our Recombinant Insulin directly from our parent company Novo Nordisk, the world’s largest producer, for a secure supply of high quality insulin. Being part ... read more

Wednesday 22.07.2020

Long seniority and high professionalism are both important cornerstones in our business. Almost half of our colleagues have a seniority above 10 years in the Novo Nordisk Group. And we actually have 9 employees (out of 193 in total) with a seniority higher than 30 years. Meet Anne Ammitzbøll. Anne has worked in the Novo Nordisk Group for 35 impressive years. She started as a Laboratory Technician and has been in her current position in our QC (Quality Control) in Køge since 1998. “My position and department have changed a lot during the years and thanks to my versatile assignments, ... read more

Wednesday 15.07.2020

Europe´s leading Bioprocessing event is taking place July 13-17 – and Novo Nordisk Pharmatech is an active part of the event. You will here get much more information about our Insulin Human AF and how it can help you in your upstream processes. The conference and exhibition was original planned for April and then moved to new dates due to COVID-19. Now it will be held as a 100% virtual event. Do you want to visit our virtual booth and have a chat with Gernot Stadlmann, Timur Özbay or Lene Hoffmeyer Nielsen? You can register for the FREE virtual exhibition ... read more

Friday 03.07.2020

Our customers depend on us to deliver their needed products – even when we are facing a pandemic as COVID-19. While our customers depend on us, we depend on our employees.  Without them and their ability to work under changed conditions, we could have faced great problems the last couple of months. Meet our Supply Chain team. As the COVID-19 pandemic was advancing, our Supply Chain team faced a big challenge: The increased amount of potential shortages that could stop production to the great disadvantage of our many customers. At the same time, they had to adapt to working remotely, ... read more

Thursday 02.07.2020

Our innovation: A wide range of capabilities are available at Novo Nordisk Pharmatech A/S within the various departments; Sales and Marketing, R&D, Manufacturing, Quality, Business Support and HR & Communication. They are all critical for us to run the business and innovate. The following “Core Capabilities” are fundamental to the future growth of our company: Designing and developing silica gels: We have long history of continuously reducing the cost for Novo Nordisk of producing insulin by providing robust silica gel and developing processes for increasing their life time. Advanced microanalysis: At our Microanalysis Centre our team supports Novo Nordisk with state-of-the-art ... read more

Thursday 11.06.2020

You can increase viable CHO cell density by supplementing with recombinant Insulin Human AF. CHO cells are one of the most widely used platforms to produce biopharmaceuticals. Increased demand for safety and reliability has moved the standard for CHO cell culture media from Serum to Serum free, and further on to chemically defined media. UAB (Universitat Autònoma de Barcelona), in collaboration with Novo Nordisk Pharmatech A/S, has shown that the addition of animal origin free insulin to three leading commercially available, off-the-shelf chemically defined media, resulted in significant increases in viable cell density under batch-mode culture. This led to improve ... read more

Thursday 04.06.2020

We will develop our employees. This is one of our goals at Novo Nordisk Pharmatech. Therefore, from the first day we encourage our employees to think about their continuing education. Not necessarily for the position they have now. But to make sure that they are ready for any future positions. Internally or externally. An example of this is our Global Marketing Manager Marie-Louise Lyster Andersen. Marie-Louise started working at Novo Nordisk Pharmatech on January 1th 2020 and has already started her first training with an external partner: “It is very satisfying to work at a company that is not reluctant ... read more

Thursday 28.05.2020

How do we ensure the quality of materials and products? What are the benefits of using cGMP Quats as excipients? And how does Novo Nordisk Pharmatech ensure to stay on top of the pace of technology change? Did you have the chance to read the article in Pharma Focus Asia, where our Corporate Vice President Rasmus Hother le Fevre talks about the industry challenges on product quality and how to ensure a good quality? If not, you can read the article here.

Friday 15.05.2020

Novo Nordisk Pharmatech has been a CO2 neutral company since 2018. This environmental improvement is due to an agreement from 2015 on energy distribution, which ensures we are only supplied with renewable energy, produced by windmills. In 2018, another agreement was made regarding our gas consumption, which now comes from Biogas. This means that we have zero CO2 emissions from energy consumption. In 2019 we also committed to the Novo Nordisk Circular for Zero environmental strategy. This means we will strive to have zero environmental impact by 2030. We are committed to the following targets, according to our environmental policy: We ... read more

Thursday 07.05.2020

Did you know that we at Novo Nordisk Pharmatech have 70 years of extensive experience supplying Quats (quaternary ammonium compounds) for the biopharmaceutical and pharmaceutical industries? Do you also know the story behind our company name? In 1949 Ferrosan Fine Chemicals factory was established. In 1986 we were acquired by Novo Nordisk. In 1992 the name was changed to FeF Chemicals A/S – and on September 1th 2015 we changed to the name, we have today: Novo Nordisk Pharmatech A/S. At the same time our current Corporate Visual Identity was created including the well-known Novo Nordisk bull. All the way ... read more

Thursday 30.04.2020

Every year, we at Novo Nordisk Pharmatech publish a single, integrated report on our performance. Read the Annual Report 2019 here and learn more about our accomplishments and results, our way of doing business and our financial statements.

Monday 27.04.2020

Imagine a blockbuster drug. Now keep it on track. Every new idea needs great execution. We can help, with a reliable supply of the highest quality ingredients for the biopharmaceutical and pharmaceutical industries: Recombinant Insulin for cell growth media and pharmaceutical grade Quaternary Ammonium Compounds. Both manufactured to cGMP standards. Our proven record of precision delivery and product quality allows you to keep development on track, production flowing, and products supplied to hospitals and patients. Giving you the security, you need to focus on the next big breakthrough. Our experts are always ready to support you. You can find their ... read more

Thursday 23.04.2020

Our full cGMP processes make Novo Nordisk Pharmatech the leading supplier of pharmaceutical grade Quats (quaternary ammonium compounds) for a wide range of applications. Benzalkonium Chloride, Cetrimide and Cetrimonium Bromide (CTAB) in cGMP grade are particularly suited as active ingredients and excipients in pharmaceuticals, or process aids for biopharmaceuticals. Proven under ICH Q1 conditions, our Quats are very stable. They are powerful antimicrobial surfactants, soluble both in aqueous and oily phases and basically active at all pH ranges. They can be used for a large number of applications requiring high purity and quality, such as ophthalmics, nasal sprays, wound care/topical/oral/dental ... read more

Thursday 16.04.2020

Almost four weeks has passed since the first announcement came that we had to rearrange our daily life to break the Corona infection chain. Plans were made in regard to prioritizing within the frame set by the authorities and it was quickly evident that we are change ready and flexible in solving that task. This way we can still ensure that our customers will receive the same high-quality products as always. One thing is the professional part of working and finding new solutions to that. Another thing is the importance of the social element, which becomes very distinct in a ... read more

Wednesday 08.04.2020

To enhance cell growth and viability for your innovative biologics, you can work with the leading supplier of recombinant insulin, Novo Nordisk Pharmatech. We source our recombinant insulin directly from our mother company Novo Nordisk, the world’ s largest insulin producer. Thanks to our solid supply chain, you can keep development on track, production flowing, and products supplied to hospitals and patients. Whether you work with HEK, CHO, SF9 insect, CAR-T or stem cells, you will be provided with the right quality ingredients for your projects, supplemented with appropriate documentation – even tailoring our solutions to match your specific application ... read more

Thursday 02.04.2020

Whether you are manufacturing bacterial or viral vaccines, you want to minimize risks in your process by only using the purest and safest ingredients and materials. CTAB, called Cetrimonium Bromide or Cetyl Trimethyl Ammonium Bromide, is a powerful cationic surfactant for use in vaccine downstream purification steps. It is recommended by the WHO for the precipitation step of polysaccharide-based bacterial vaccines. It is also used as a purification agent of viral antigens, whether the vaccine is egg-based, cell-based or recombinant. Utilizing chttps://www.linkedin.com/company/68003/GMP manufactured, pharma grade ingredients and processing aids can help you secure your vaccine production and minimize your risks. ... read more

Friday 27.03.2020

COVID-19: Looking for an effective antimicrobial agent? Benzalkonium Chloride (BKC) is recommended by several national agencies as an effective agent to control infection by Covid-19. BKC, a Quaternary Ammonium Compound (or Quat), is an ideal antimicrobial agent with proven efficacy. It is broadly used in topical and wound care products such as hand sanitizers, antiseptic liquids, foams, gels and cleansing wipes. BKC acts on a wide range of microorganisms, including enveloped viruses such as influenza and Corona, gram+ and gram- bacteria such as MRSA, moulds and yeasts such as Candida albicans. As opposed to bacteriostatic/fungistatic compounds which only prevent micro-organisms ... read more

Friday 20.03.2020

The vaccine industry is challenged to produce large quantities of vaccines in a rapid and cost-effective way. Major changes to current bioprocesses are both difficult and very expensive to implement. Using HEK293, it has been demonstrated that addition of recombinant human insulin to commercially available chemically defined media can be used as a supplement to increase VCD and specific viral yield. If you want to know more you can read the application study, which National Research Council Canada has created in collaboration with Novo Nordisk Pharmatech A/S here.

Friday 13.03.2020

Novo Nordisk Pharmatech A/S is continuously reviewing the likely impact upon its supply chain if product availability is affected by the consequences of the coronavirus. Presently, we conclude that the impact on current product portfolio is very limited. We will keep our customers informed of developments that might affect product supply and demand if the situation changes. You can read the full statement here

Thursday 12.03.2020

In our ambition to build and maintain customer loyalty all around the world, Novo Nordisk Pharmatech A/S started using NPS (Net Promotor Score) in 2014. It was – and still is – a simple tool to clarify if our customers are as satisfied as we think they are and whether they would recommend us to others. We also receive great input in the comments on where we can improve our business. Since 2014 we have significantly improved our NPS score*, and in 2019 we had an impressive average score of 76. NPS scores range from -100 to 100. Do you also ... read more

Monday 10.02.2020

At Novo Nordisk Pharmatech we always strive to develop and provide high quality products and services that place emphasis on the health and safety of our consumers and customers. As of January 1st, 2020 our new Director of Manufacturing is John Halfdan Boiesen. John will be heading up the NNPR manufacturing facility ensuring that we deliver high quality products in regulatory compliance. Part of the Manufacturing responsibility is to ensure that NNPR has all necessary permissions to operate and operate with minimal environmental impact. John Boiesen started his career at Novo Nordisk in 2005 as a Supply Chain Graduate and ... read more

Friday 31.01.2020

We are pleased to announce that Chantale Julien has re-joined Novo Nordisk Pharmatech on January 1st, 2020. Chantale will be acting as Global Product Manager for the FeF Quats and Insulin Human AF products. Chantale has previously worked for Novo Nordisk Pharmatech for a period stretching over almost 13 years, where she has been acting as Product Manager, Regulatory Affairs Manager and Project Manager. She has been involved in establishing the Insulin Human AF distribution from Novo Nordisk Pharmatech and brings back a wide experience in the API and excipient sectors for our antimicrobial quaternary ammonium compounds. We are happy to have ... read more

Thursday 23.01.2020

The grand opening of Novo Nordisk Pharmatech A/S new branch office in Singapore on October 15th 2019 was celebrated together with customers, employees and other stakeholders. At Novo Nordisk Pharmatech A/S we opened our first overseas representative office with a Grand Opening ceremony for our new branch in Singapore. The event marks a significant new expansion milestone in the 70-year history of Novo Nordisk Pharmatech. The new branch office at 152 Beach Road, #17-04 The Gateway East has been in operation since September, serving as a hub to expand Novo Nordisk Pharmatech’s business across Asia. The region is a rapidly growing market ... read more

Friday 11.10.2019

Novo Nordisk Pharmatech A/S has entered into an agreement with Signet Chemical Corporation Pvt. Ltd. for the distribution of their pharmaceutical range of quaternary ammonium compounds (FEF® Quats) to the healthcare industry in India, Bangladesh and Sri Lanka. Mr. Harish Shah – managing director of Signet commented on this new collaboration: “We are pleased to be associated with Novo Nordisk Pharmatech which is the leading supplier of Quats to the pharmaceutical and biopharmaceutical markets. Novo Nordisk Pharmatech’s FeF® Quats complement our existing portfolio of excipients used especially for ophthalmic, nasal and topical dosage forms”. Novo Nordisk Pharmatech A/S manufactures Quats ... read more

Tuesday 31.07.2018

Novo Nordisk Pharmatech and Brenntag Specialties, Inc. (BSI) have entered into a distribution agreement for Pharmaceutical Grade Quaternary Ammonium Compounds into the Pharmaceutical and OTC Markets in the United States & Puerto Rico. “Our partnership with Novo Nordisk Pharmatech demonstrates our commitment to providing innovative solutions and differentiated value to our customers by strategically expanding our principal relationships and product lines.” said Steve Brauer, President of Brenntag Specialties, Inc. “The product line offering from Novo Nordisk Pharmatech furthers our reach into the pharmaceutical, OTC, and personal care markets” Novo Nordisk Pharmatech manufactures its Pharmaceutical Grade Quaternary Ammonium Compounds in accordance ... read more

Saturday 01.07.2017